Epitome Residency Private Limited - Company Profile

It is a real estate and construction private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 Mumbai, Maharashtra, India Under Cirp
Last Updated:
Access Report
About Epitome Residency Private Limited

Epitome Residency Private Limited, a under cirp private limited company, was established on 03 July 2008 in Mumbai, Maharashtra, India. Engaging in real estate builders & developers within the construction sector, it holds CIN: U45100MH2008PTC184241. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.75 Cr and a paid-up capital of ₹0.14 M.

Formerly known as Epitome Realty Projects Private Limited, Wadhwa Power Private Limited. It upholds a compliant status. Employing 34 professional, Its leadership includes Sanjay Rajkumar Chhabria (Director), Anil Nandlal Chhabria (Director), Bharat Ramakant Upadhyay (Irp/Rp/Liquidator). Past directors included Vijay Vasudev Wadhwa, Sanjay Rajkumar Chhabria, Anil Nandlal Chhabria. It holds ₹147.00 Cr open charges and ₹700.36 Cr settled loans. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at One Bkc, A Wing 1401, Plot No. C-66, G Block, Bandra Kurla Complex, Bandra (E, Ast),, Mumbai, Maharashtra, 400051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U45100MH2008PTC184241

  • Registration Number

    184241

  • Incorporation Date

    03 July 2008

  • Authorized Capital

    ₹3.75 Cr

  • Paid-Up Capital

    ₹0.14 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Under Cirp

Key Metrics
  • Authorised Capital ₹ 3.75 Cr
  • Paid Up Capital ₹ 0.14 M
  • Company Age 18 Year, 3 Days
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 147.00 Cr
  • Satisfied Charges ₹ 700.36 Cr
  • Revenue Growth **** -68.25%
  • Profit Growth **** -31.52%
  • Ebitda **** -666.85%
  • Net Worth -123.77%
  • Total Assets **** 107.70%
Company report

Epitome Residency Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Epitome Residency Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Epitome Residency Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Rajkumar Chhabria Director 31 Mar 2017 Current
Anil Nandlal Chhabria Director 31 Mar 2017 Current
Bharat Ramakant Upadhyay Irp/Rp/Liquidator 29 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2017 Past
Pramod Abcsdd Director 23 Jul 2014 Past
Pramod Abcsdd Additional Director 28 Sep 2017 Past
Pramod Abcsdd Irp/Rp/Liquidator 11 May 2024 Past
Pramod Abcsdd Director 31 Mar 2017 Past
Pramod Abcsdd Additional Director 14 Oct 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Epitome Residency.

Epitome Residency Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 68.25% decrease. The company also saw a substantial fall in profitability, with a 31.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 123.77%.

Epitome Residency revenue growth over time
Epitome Residency profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -68.25%
*******
*******
*******
*******
Revenue from Operations
*******
 -66.25%
*******
*******
*******
*******
Total Assets
*******
 107.70%
*******
*******
*******
*******
Profit or Loss
*******
 -31.52%
*******
*******
*******
*******
Net Worth
*******
 -123.77%
*******
*******
*******
*******
EBITDA
*******
 -666.85%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Epitome Residency?

In 2019, Epitome Residency had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,470,000,000.00

Satisfied Charges

₹7,003,606,356.00

Charges Breakdown by Lending Institutions
  • Others : 147.00 Cr
Latest Charge Details
Date Lender Amount Status
11 Sep 2017 Others ₹45.00 Cr Open
13 Apr 2017 Others ₹45.00 Cr Open
13 Apr 2017 Others ₹57.00 Cr Open
16 Sep 2019 Others ₹288.86 Cr Satisfied
16 Sep 2019 Others ₹267.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Epitome Residency?

Epitome Residency has a workforce of 34 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Epitome Residency, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epitome Residency's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Epitome Residency
Recent Activity within the Organization
  • Director Appointment

    The activity Bharat Ramakant Upadhyay was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 29 May 2025 & has been associated with this company since 1 year 1 month . was completed.

  • Charges

    The activity A charge registered on 16 Sep 2019 via Charge ID 100291615 with Others was fully satisfied on 25 Apr 2021. was completed.

  • Charges

    The activity A charge registered on 16 Sep 2019 via Charge ID 100291611 with Others was fully satisfied on 25 Apr 2021. was completed.

  • Annual General Meeting

    The activity Epitome Residency Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Epitome Residency Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 288.86 Cr with Charge ID 100291615 was registered on 16 Sep 2019. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Epitome Residency Private Limited?

The CIN of Epitome Residency Private Limited is U45100MH2008PTC184241.

Where is Epitome Residency Private Limited headquartered?

Epitome Residency Private Limited is headquartered at One Bkc, A Wing 1401, Plot No. C-66, G Block, Bandra Kurla Complex, Bandra (E, Ast),, Mumbai, Maharashtra, 400051.

When was Epitome Residency Private Limited incorporated?

Epitome Residency Private Limited was incorporated on 03 July 2008.

Who are the current directors of Epitome Residency Private Limited?

The current directors of Epitome Residency Private Limited are

What is the primary industry of Epitome Residency Private Limited?

The primary industry of Epitome Residency Private Limited is Construction.

Is Epitome Residency Private Limited a listed company?

Epitome Residency Private Limited is unlisted.

What is the capital structure of Epitome Residency Private Limited?

The authorized capital of Epitome Residency Private Limited is ₹3.75 Cr, and the paid-up capital is ₹0.14 M.

What is the compliance status of Epitome Residency Private Limited?

The compliance status of Epitome Residency Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available